In an effort to further increase our transparency towards our investors, we have launched Oncopeptalks, a video series where we discuss recent and future company events relevant to the investor community. The videos are produced inhouse in order to premier speed and cost efficiency before high level production value and we aim to produce videos both following major news but also in order to bring forward some of the many exciting initiatives and people that is Oncopeptides.
In the latest, and “final”, Oncopeptalks, Sofia covers, among other things, congress season, and David provides some updates from the communications side – including that Oncopeptalks will take on a new shape in the future.
In the latest episode of Oncopeptalks, Sofia Heigis talks more about recent initiatives to strengthen access to real‑world data in the company’s key markets. She also answers a number of questions from investors on everything from the sales landscape in Germany and Italy to the recently completed share issue.
The video is available in Swedish, with Swedish or English subtitles.
In the latest episode of Oncopeptalks, David and Sofia talk about the newly released Q4 report, the ongoing rights issue and news about our pipeline. The video is available in Swedish with English subtitles.
In the last episode of the year, David and Sofia discuss the key takeaways from the year and from ASH. The video is available in Swedish with English subtitles.
In the latest episode of Oncopeptalks, David and Sofia talk about the ongoing rights issue, the European market and the participation in the big myeloma congress IMS in Toronto, Canada.
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
